Annandale Capital’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-889
| Closed | -$6K | – | 127 |
|
|
2024
Q4 | $6K | Hold |
889
| – | – | ﹤0.01% | 119 |
|
|
2024
Q3 | $11K | Buy |
+889
| New | +$11K | ﹤0.01% | 119 |
|
|
2024
Q2 | – | Sell |
-889
| Closed | -$44K | – | 140 |
|
|
2024
Q1 | $44K | Sell |
889
-1,600
| -64% | -$79.2K | 0.01% | 128 |
|
|
2023
Q4 | $188K | Hold |
2,489
| – | – | 0.04% | 122 |
|
|
2023
Q3 | $209K | Buy |
2,489
+711
| +40% | +$59.7K | 0.05% | 106 |
|
|
2023
Q2 | $247K | Hold |
1,778
| – | – | 0.07% | 110 |
|
|
2023
Q1 | $513K | Hold |
1,778
| – | – | 0.16% | 87 |
|
|
2022
Q4 | $464K | Buy |
1,778
+200
| +13% | +$52.2K | 0.15% | 91 |
|
|
2022
Q3 | $422K | Buy |
1,578
+709
| +82% | +$190K | 0.16% | 90 |
|
|
2022
Q2 | $290K | Buy |
869
+425
| +96% | +$142K | 0.11% | 108 |
|
|
2022
Q1 | $272K | Buy |
+444
| New | +$272K | 0.11% | 96 |
|